Clarke CS, Hunter RM, Gabrio A, Brawley CD, et al. Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data. PLoS One 2022;17:e0269192.
PMID: 35653395